Related Experiment Video

Updated: Jul 10, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Thrombocytosis and thrombosis

Alessandro M Vannucchi1, Tiziano Barbui

  • 1Department of Hematology, University of Florence, Azienda Ospedaliera-Universitaria Careggi, 50134 Florence, Italy. amvannucchi@unifi.it

Hematology. American Society of Hematology. Education Program
|November 21, 2007
PubMed

Insights

This review discusses diagnosing thrombocytosis, focusing on molecular mutations like JAK2V617F in chronic myeloproliferative disorders (CMPD). Accurate diagnosis still requires bone marrow evaluation despite these genetic markers.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Thrombocytosis, or elevated platelet counts, is often linked to chronic myeloproliferative disorders (CMPD).
  • Specific molecular mutations, including JAK2V617F and MPLW515L/K, are increasingly identified in CMPD patients.
  • Distinguishing primary thrombocytosis from reactive causes and classifying CMPD subtypes remains challenging.

Purpose of the Study:

  • To review current diagnostic strategies for thrombocytosis.
  • To integrate new molecular findings into the classification of CMPD.
  • To discuss the role of thrombocytosis in thrombosis and hemorrhage.

Main Methods:

  • Literature review of diagnostic approaches for thrombocytosis.
  • Analysis of molecular abnormalities (JAK2V617F, MPLW515L/K) in CMPD.
  • Evaluation of bone marrow histology's role in diagnosis.

Main Results:

  • JAK2V617F and MPLW515L/K mutations are prevalent in essential thrombocythemia, polycythemia vera, and primary myelofibrosis.
  • These mutations are not universally present or disease-specific, necessitating a comprehensive diagnostic approach.
  • Bone marrow histology is crucial for differentiating CMPD subtypes and reactive thrombocytosis.

Conclusions:

  • Despite molecular discoveries, a multifaceted diagnostic approach including bone marrow histology is essential for thrombocytosis.
  • Understanding molecular drivers like JAK2V617F aids in risk stratification for thrombosis and hemorrhage.
  • Current and emerging management strategies for thrombocytosis are critical for patient outcomes.

More Related Videos

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...